Course Director:
Manju T. Beier, Pharm..D., FASCP
President, Geriatric Consultant Resources, LLC
Clinical Assistant Professor, College of Pharmacy
University of Michigan, Ann Arbor, Michigan, USA

Upon completion of this program, the participant should be able to:

1. Describe the epidemiology and pathophysiology of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).

2. Discuss differences in clinical presentation and management of PUD in elderly patients compared with younger adults.

3. Describe invasive and non-invasive diagnostic methods for H. pylori, and explain how to determine which patients should be included in this process.

4. Select and justify the most effective drug regimen and duration for eradication of H. pylori in a given patient, with reference to national guidelines.

5. Compare the clinical presentation and management of mild versus severe GERD.

6. Identify the most effective acute and maintenance pharmacologic regimen for GERD in patients with different disease severities.

7. Outline adverse effects, dosage adjustments, and monitoring parameters of medications used in the management of PUD and GERD

Target audience
Geriatric health-care practitioners

Accreditation
At this time we are offering CE for pharmacists only. The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Release Date: June 1999
Second Release date: November 2003
Expiration Date: November 2006

This program (Program {INDIVIDUAL PROGRAM NUMBER #203-999-03-607-H01)} qualifies for 0.1 CEUs (1.0 contact hours) of continuing pharmacy education. CEUs will be awarded provided that the participant reviews this site and scores 70% or better on the post test that follows. To receive a statement of credit, please complete the examination and evaluation that follows this program. A statement will be awarded and mailed to you within 4-6 weeks.

The information provided in these programs is intended solely for the continuing educational needs of health-care practitioners. The medications discussed in these programs have Food and Drug Administration approval in the US. Individuals should not exclusively rely upon the information provided in these programs.

The continuing education programs are offered “as is.” Geriatric Consultant Resources, LLC disclaims all warranties and representations, express or implied, with respect to the programs and the information contained therein, including without limitation any and all warranties of title, non infringement, merchantability, or fitness for any particular purpose. Without limiting the foregoing, Geriatric Consultant Resources LLC shall not be responsible for any inaccuracy or omission in the information contained in the programs, and shall have no liability whatsoever of any kind resulting from any claim or action arising out of the use of the programs.